GlaxoSmithKline PLC (GSK) stock prices updated...
 

GlaxoSmithKline PLC stock price

GlaxoSmithKline PLC latest news:


  • 10/13/2017 11:37:21

    BRIEF-Glaxosmithkline says ‍shingles vaccine approved in Canada

    Glaxosmithkline Plc(GSK): * ‍SHINGRIX HAS BEEN APPROVED IN CANADA FOR PREVENTION OF SHINGLES IN PEOPLE AGED 50 YEARS OR OLDER​. * ‍APPROVAL IN CANADA WAS BASED ON PHASE III CLINICAL TRIAL PROGRAMME EVALUATING ITS EFFICACY, SAFETY AND IMMUNOGENICITY IN MORE THAN 37,000 PEOPLE​ Source text for Eikon: Further company coverage:

  • 09/20/2017 00:16:27

    BRIEF-GlaxoSmithkline and Innoviva announces positive impact results for Trelegy in COPD

    * CO, INNOVIVA REPORT POSITIVE HEADLINE RESULTS FROM STUDY SHOWING SINGLE INHALER TRIPLE THERAPY TRELEGY ELLIPTA REDUCED COPD EXACERBATIONS

  • 09/15/2017 00:15:22

    BRIEF-GlaxoSmithKline says Trelegy Ellipta once-daily single inhaler triple therapy receives positive opinion from CHMP in Europe

    * TRELEGY ELLIPTA ONCE-DAILY SINGLE INHALER TRIPLE THERAPY RECEIVES POSITIVE OPINION FROM THE CHMP IN EUROPE FOR APPROPRIATE PATIENTS WITH COPD

  • 09/14/2017 00:19:04

    BRIEF-GlaxoSmithKline announces unanimous FDA approval for Shingrix in over 50s

    * FDA ADVISORY COMMITTEE VOTES UNANIMOUSLY FOR SHINGRIX (HZ/SU) IN US FOR PREVENTION OF HERPES ZOSTER (SHINGLES) IN ADULTS AGES 50 AND OVER​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

  • 08/24/2017 00:56:15

    Novartis picks retail expert for new role of digital chief

    LONDON, Aug 24 (Reuters) - Novartis has appointed a senior retail expert to the new post of chief digital officer, following a similar move by GlaxoSmithKline last month, underscoring how drugmakers are grappling with the impact of new technology.

  • 08/10/2017 10:16:26

    UK fraud office expects decision on GSK, Rolls-Royce cases next year

    LONDON, Aug 10 (Reuters) - The UK Serious Fraud Office (SFO) said on Thursday it expects to decide next year whether it will file criminal charges in bribery investigations related to drugs giant GlaxoSmithKline and aero engine company Rolls-Royce.

  • 08/04/2017 06:47:14

    United Therapeutics Corp. stock surges 9% on report of possible bids for company

    United Therapeutics Corp. shares surged 8.7% premarket on Friday after a news report suggested that major pharmaceutical companies were weighing a bid for it. The Evening Standard report said that Gilead Sciences Inc. is considered the frontrunner, while GlaxoSmithKline PLC and Novartis AG are also possible contenders. Glaxo and United Therapeutics declined to comment to the Evening Standard. United Therapeutic, which was founded by Martine Rothblatt, a co-founder of Sirius XM , currently has five products on the market, four of which treat pulmonary arterial hypertension; the fifth is intended for pediatric cancer patients. United Therapeutics shares have dropped 11.5% year-to-date, compared with a 10.4% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/26/2017 10:59:54

    GSK gives up on rare diseases as gene therapy gets two customers

    LONDON, July 26 (Reuters) - GlaxoSmithKline is swimming against the tide by getting out of treatments for rare diseases at a time when rivals like Sanofi and Shire see the field as a rich seam for profits.

  • More trends:

    Global Brass and Copper HoldingsBRSS | Global Cash Access HoldingsGCA | Global High Income Dollar FundGHI | Global Net LeaseGNL | Global Partners LPGLP | Global Payments Inc.GPN | Global Power Equipment Group IncGLPW | Global Ship LeaseGSL | Global Ship LeaseGSL^B | Globant S.A.GLOB |